HLA-C and neoplasm: Tumours can dynamically adapt to therapeutic pressures by modulating immune checkpoints, secreting immunosuppressive cytokines, recruiting regulatory immune cells, or altering antigen processing pathways, thereby creating an immunosuppressive microenvironment that counteracts the benefits of enhanced MHC expression.